Skip to main content
Journal of Virology logoLink to Journal of Virology
. 1993 Jul;67(7):4316–4322. doi: 10.1128/jvi.67.7.4316-4322.1993

Hepatitis B virus (HBV) binding factor in human serum: candidate for a soluble form of hepatocyte HBV receptor.

A Budkowska 1, C Quan 1, F Groh 1, P Bedossa 1, P Dubreuil 1, J P Bouvet 1, J Pillot 1
PMCID: PMC237802  PMID: 8510225

Abstract

A hepatitis B virus (HBV) binding factor (HBV-BF) was identified in normal human serum interacting with the pre-S1 and pre-S2 epitopes of the viral envelope located within the protein domains involved in recognition of hepatocyte receptor(s). This molecule was characterized as a 50-kDa glycoprotein showing an isoelectric point of 7.13 with a biological activity depending on its native molecular conformation and on intact sulfhydryl bonds. Monoclonal antibodies to HBV-BF recognized a membrane component of the normal human liver whereas they were unreactive with hepatocyte membranes of other species and with those of the HepG2 cell line. These results suggest that the HBV-BF represents a soluble fragment of the membrane component and can be related to the HBV receptor mediating attachment of HBV to human liver cells.

Full text

PDF
4316

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Budkowska A., Dubreuil P., Maillard P., Poynard T., Pillot J. A biphasic pattern of anti-pre-S responses in acute hepatitis B virus infection. Hepatology. 1990 Dec;12(6):1271–1277. doi: 10.1002/hep.1840120604. [DOI] [PubMed] [Google Scholar]
  2. Budkowska A., Riottot M. M., Dubreuil P., Lazizi Y., Brechot C., Sobczak E., Petit M. A., Pillot J. Monoclonal antibody recognizing pre-S(2) epitope of hepatitis B virus: characterization of pre-S(2) epitope and anti-pre-S(2) antibody. J Med Virol. 1986 Oct;20(2):111–125. doi: 10.1002/jmv.1890200204. [DOI] [PubMed] [Google Scholar]
  3. Dash S., Rao K. V., Panda S. K. Receptor for pre-S1(21-47) component of hepatitis B virus on the liver cell: role in virus cell interaction. J Med Virol. 1992 Jun;37(2):116–121. doi: 10.1002/jmv.1890370208. [DOI] [PubMed] [Google Scholar]
  4. Deen K. C., McDougal J. S., Inacker R., Folena-Wasserman G., Arthos J., Rosenberg J., Maddon P. J., Axel R., Sweet R. W. A soluble form of CD4 (T4) protein inhibits AIDS virus infection. Nature. 1988 Jan 7;331(6151):82–84. doi: 10.1038/331082a0. [DOI] [PubMed] [Google Scholar]
  5. Fernandez-Botran R. Soluble cytokine receptors: their role in immunoregulation. FASEB J. 1991 Aug;5(11):2567–2574. doi: 10.1096/fasebj.5.11.1868981. [DOI] [PubMed] [Google Scholar]
  6. Fujimoto J., Levy S., Levy R. Spontaneous release of the Leu-2 (T8) molecule from human T cells. J Exp Med. 1983 Sep 1;158(3):752–766. doi: 10.1084/jem.158.3.752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Heermann K. H., Goldmann U., Schwartz W., Seyffarth T., Baumgarten H., Gerlich W. H. Large surface proteins of hepatitis B virus containing the pre-s sequence. J Virol. 1984 Nov;52(2):396–402. doi: 10.1128/jvi.52.2.396-402.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Itoh Y., Takai E., Ohnuma H., Kitajima K., Tsuda F., Machida A., Mishiro S., Nakamura T., Miyakawa Y., Mayumi M. A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees. Proc Natl Acad Sci U S A. 1986 Dec;83(23):9174–9178. doi: 10.1073/pnas.83.23.9174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Khayat D., Dux Z., Anavi R., Shlomo Y., Witz I. P., Ran M. Circulating cellfree Fc gamma 2b/gamma 1 receptor in normal mouse serum: its detection and specificity. J Immunol. 1984 May;132(5):2496–2501. [PubMed] [Google Scholar]
  10. Krangel M. S. Secretion of HLA-A and -B antigens via an alternative RNA splicing pathway. J Exp Med. 1986 May 1;163(5):1173–1190. doi: 10.1084/jem.163.5.1173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Leung D. W., Spencer S. A., Cachianes G., Hammonds R. G., Collins C., Henzel W. J., Barnard R., Waters M. J., Wood W. I. Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature. 1987 Dec 10;330(6148):537–543. doi: 10.1038/330537a0. [DOI] [PubMed] [Google Scholar]
  12. MacDonald R. G., Tepper M. A., Clairmont K. B., Perregaux S. B., Czech M. P. Serum form of the rat insulin-like growth factor II/mannose 6-phosphate receptor is truncated in the carboxyl-terminal domain. J Biol Chem. 1989 Feb 25;264(6):3256–3261. [PubMed] [Google Scholar]
  13. Marlin S. D., Staunton D. E., Springer T. A., Stratowa C., Sommergruber W., Merluzzi V. J. A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection. Nature. 1990 Mar 1;344(6261):70–72. doi: 10.1038/344070a0. [DOI] [PubMed] [Google Scholar]
  14. Michel M. L., Pontisso P., Sobczak E., Malpièce Y., Streeck R. E., Tiollais P. Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin. Proc Natl Acad Sci U S A. 1984 Dec;81(24):7708–7712. doi: 10.1073/pnas.81.24.7708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Mimms L. T., Floreani M., Tyner J., Whitters E., Rosenlof R., Wray L., Goetze A., Sarin V., Eble K. Discrimination of hepatitis B virus (HBV) subtypes using monoclonal antibodies to the PreS1 and PreS2 domains of the viral envelope. Virology. 1990 Jun;176(2):604–619. doi: 10.1016/0042-6822(90)90031-l. [DOI] [PubMed] [Google Scholar]
  16. Neurath A. R., Kent S. B., Parker K., Prince A. M., Strick N., Brotman B., Sproul P. Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing. Vaccine. 1986 Mar;4(1):35–37. doi: 10.1016/s0264-410x(86)80001-9. [DOI] [PubMed] [Google Scholar]
  17. Neurath A. R., Kent S. B., Strick N., Parker K. Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell. 1986 Aug 1;46(3):429–436. doi: 10.1016/0092-8674(86)90663-x. [DOI] [PubMed] [Google Scholar]
  18. Neurath A. R., Seto B., Strick N. Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective. Vaccine. 1989 Jun;7(3):234–236. doi: 10.1016/0264-410x(89)90235-1. [DOI] [PubMed] [Google Scholar]
  19. Neurath A. R., Strick N. Antigenic mimicry of an immunoglobulin A epitope by a hepatitis B virus cell attachment site. Virology. 1990 Oct;178(2):631–634. doi: 10.1016/0042-6822(90)90368-2. [DOI] [PubMed] [Google Scholar]
  20. Neurath A. R., Strick N., Sproul P., Ralph H. E., Valinsky J. Detection of receptors for hepatitis B virus on cells of extrahepatic origin. Virology. 1990 Jun;176(2):448–457. doi: 10.1016/0042-6822(90)90014-i. [DOI] [PubMed] [Google Scholar]
  21. Neurath A. R., Strick N., Sproul P. Search for hepatitis B virus cell receptors reveals binding sites for interleukin 6 on the virus envelope protein. J Exp Med. 1992 Feb 1;175(2):461–469. doi: 10.1084/jem.175.2.461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Novick D., Engelmann H., Wallach D., Rubinstein M. Soluble cytokine receptors are present in normal human urine. J Exp Med. 1989 Oct 1;170(4):1409–1414. doi: 10.1084/jem.170.4.1409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Omata M. Significance of extrahepatic replication of hepatitis B virus. Hepatology. 1990 Aug;12(2):364–366. doi: 10.1002/hep.1840120226. [DOI] [PubMed] [Google Scholar]
  24. Peakman M., Senaldi G., Foote N., McManus T. J., Vergani D. Naturally occurring soluble CD4 in patients with human immunodeficiency virus infection. J Infect Dis. 1992 May;165(5):799–804. doi: 10.1093/infdis/165.5.799. [DOI] [PubMed] [Google Scholar]
  25. Petit M. A., Capel F., Dubanchet S., Mabit H. PreS1-specific binding proteins as potential receptors for hepatitis B virus in human hepatocytes. Virology. 1992 Mar;187(1):211–222. doi: 10.1016/0042-6822(92)90309-d. [DOI] [PubMed] [Google Scholar]
  26. Pontisso P., Petit M. A., Bankowski M. J., Peeples M. E. Human liver plasma membranes contain receptors for the hepatitis B virus pre-S1 region and, via polymerized human serum albumin, for the pre-S2 region. J Virol. 1989 May;63(5):1981–1988. doi: 10.1128/jvi.63.5.1981-1988.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Pontisso P., Ruvoletto M. G., Gerlich W. H., Heermann K. H., Bardini R., Alberti A. Identification of an attachment site for human liver plasma membranes on hepatitis B virus particles. Virology. 1989 Dec;173(2):522–530. doi: 10.1016/0042-6822(89)90564-3. [DOI] [PubMed] [Google Scholar]
  28. Pontisso P., Ruvoletto M. G., Tiribelli C., Gerlich W. H., Ruol A., Alberti A. The preS1 domain of hepatitis B virus and IgA cross-react in their binding to the hepatocyte surface. J Gen Virol. 1992 Aug;73(Pt 8):2041–2045. doi: 10.1099/0022-1317-73-8-2041. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES